107 related articles for article (PubMed ID: 3120775)
1. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
Soeda S; Kakiki M; Shimeno H; Nagamatsu A
Biochim Biophys Acta; 1987 Dec; 916(3):279-87. PubMed ID: 3120775
[TBL] [Abstract][Full Text] [Related]
2. Localization of the binding site of tissue-type plasminogen activator to fibrin.
Ichinose A; Takio K; Fujikawa K
J Clin Invest; 1986 Jul; 78(1):163-9. PubMed ID: 3088041
[TBL] [Abstract][Full Text] [Related]
3. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
de Munk GA; Caspers MP; Chang GT; Pouwels PH; Enger-Valk BE; Verheijen JH
Biochemistry; 1989 Sep; 28(18):7318-25. PubMed ID: 2510823
[TBL] [Abstract][Full Text] [Related]
4. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
Bakker AH; Rehberg EF; Marotti KR; Verheijen JH
Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of the binding of plasminogen to heparin: evidence for the involvement of lysine residues.
Soeda S; Ohki H; Shimeno H; Nagamatsu A
Biochim Biophys Acta; 1989 Nov; 999(1):29-35. PubMed ID: 2572276
[TBL] [Abstract][Full Text] [Related]
6. A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin-binding and tissue plasminogen activator catalytic domains.
Robbins KC; Boreisha IG
Biochemistry; 1987 Jul; 26(15):4661-7. PubMed ID: 3117104
[TBL] [Abstract][Full Text] [Related]
7. Effects of monoclonal antibodies on tissue-type plasminogen activator (t-PA) binding to lysine, fibrin and heparin and on fibrin-mediated enhancement of one-chain t-PA amidolytic activity.
Fischer B; Zacharias U; Will H
Biol Chem Hoppe Seyler; 1991 Apr; 372(4):263-71. PubMed ID: 1905550
[TBL] [Abstract][Full Text] [Related]
8. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.
Andrade-Gordon P; Strickland S
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1865-9. PubMed ID: 2106684
[TBL] [Abstract][Full Text] [Related]
9. Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin(ogen) is important for t-PA activity.
Kaczmarek E; Lee MH; McDonagh J
J Biol Chem; 1993 Feb; 268(4):2474-9. PubMed ID: 8428923
[TBL] [Abstract][Full Text] [Related]
10. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
van Zonneveld AJ; Veerman H; Pannekoek H
J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732
[TBL] [Abstract][Full Text] [Related]
11. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
Andrade-Gordon P; Strickland S
Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of fibrin-binding affinity of fibrinolytic components by frontal affinity chromatography.
Kazama M; Tahara C; Abe T; Kasai K
Thromb Res Suppl; 1988; 8():81-90. PubMed ID: 3144771
[TBL] [Abstract][Full Text] [Related]
13. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
14. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
Fischer B
Biomed Biochim Acta; 1991; 50(1):47-54. PubMed ID: 1830477
[TBL] [Abstract][Full Text] [Related]
15. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
Boutaud A; Castellino FJ
Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule.
Urano T; Takada Y; Takada A
Biochim Biophys Acta; 1991 Apr; 1077(3):245-52. PubMed ID: 1903067
[TBL] [Abstract][Full Text] [Related]
17. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
18. Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin.
Stack MS; Pizzo SV
J Biol Chem; 1993 Sep; 268(25):18924-8. PubMed ID: 8360182
[TBL] [Abstract][Full Text] [Related]
19. Some properties of tissue-type plasminogen activator reconstituted onto phospholipid and/or glycolipid vesicles.
Soeda S; Kakiki M; Shimeno H; Nagamatsu A
Biochem Biophys Res Commun; 1987 Jul; 146(1):94-100. PubMed ID: 3111472
[TBL] [Abstract][Full Text] [Related]
20. Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin.
Wallén P; Bergsdorf N; Rånby M
Biochim Biophys Acta; 1982 Nov; 719(2):318-28. PubMed ID: 6891267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
